ABSTRACT-The effects of cerebral metabolism-improving drugs on NADPH diaphorase activity in the mouse brain were studied, and we found that diaphorase activity in the post-mitochondrial fraction of brain homogenate was enhanced by idebenone in a concentration-dependent manner. Histochemical studies also indicated that diaphorase staining was intensified by idebenone at the same concentration. These results sug gest that idebenone may stimulate the production of nitric oxide, probably through its direct action on nitric oxide synthase, thus producing its protective action on neurological disorders due to cerebral hypoxia or ischemia as a consequence of dilating the cerebral blood vessels.
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Nitric oxide has recently been proposed to play a phys iologically important role as an endogenous factor regulat ing vascular tone in cerebral blood vessels (1 5) . In addi tion to its role as a vascular relaxing factor derived from endothelium, nitric oxide has also been proposed to play a role as a putative neurotransmitter in the non-adrener gic and non-cholinergic neurons, based on the recent im munohistochemical studies indicating that nitric oxide synthase is localized in the central and peripheral nervous systems (6) (7) (8) . In view of these findings, it seems reason able to consider that nitric oxide may be able to influence the cerebral metabolism, presumably through the modula tion of cerebral blood flow that results from its dilatory action on cerebral blood vessels. On the other hand, sev eral drugs affecting the cerebral metabolism and/or blood flow have been developed in expectation of their clinical effectiveness for treating neurological disorders due to cerebral hypoxia or ischemia. The effects of these drugs on the metabolism of neurotransmitters have been stud ied to elucidate the mechanism of their pharmacological actions. However, the mechanism of their improving ac tions on cerebral metabolism still remains to be elucidat ed. As a possible mechanism, it is conceivable that the im provement of cerebral blood flow induced by these drugs may be closely related to their stimulatory actions on the production of nitric oxide in the brain. In the recent stud ies, NADPH diaphorase has already been reported to be a nitric oxide synthase (9) , and the nerve fibers containing NADPH diaphorase have been shown to innervate the cerebral blood vessels (10) . In the present study, the activ ity of NADPH diaphorase was therefore determined as an index for the activity of nitric oxide synthase, and the effects of cerebral metabolism-improving drugs on the production of nitric oxide were examined by measuring this enzyme activitiy using biochemical and histochemical techniques. Adult male ddY mice (25 30 g) were killed by decapi tation, and whole brains were quickly removed and homogenized in 10 volumes of 10 mM Tris-HC1 buffer (pH 7.4). The homogenate was centrifuged at 20,000 X g for 20 min, and the resulting supernatant fraction was used for the determination of NADPH diaphorase activ ity as a crude enzyme. The enzyme activity was assayed by measuring the reduction of nitro blue tetrazolium (NBT) to its formazan product during the incubation period. The mixture containing 50 mM Tris-HCl (pH 8.0), 0.5 mM NBT, 1 mM NADPH, and the crude enzyme (240 pg protein) in a volume of 0.5 ml was incubated at 37 °C for 20 min, and the reaction was terminated by adding 0.5 ml of 0.1 M sulfuric acid. The incubation mixture was cen trifuged at 1,500 x g for 10 min to clarify the solution, and the absorbance of formazan product was determined at 585 nm.
Mice were transcardially perfused in deep anesthesia with 0.1 M phosphate buffer (pH 7.4) containing 10 units/ml of heparin sulfate followed by 0.1 M phosphate buffer containing 4% paraformaldehyde and 0.2% picric acid. Brains were removed and postfixed for 2 hr in the same fixative, and then placed in 10%, 15% and 20% su crose in 10 mM phosphate-buffered saline for cryoprotec tion. The tissues were sectioned serially with a cryostat at 10-pm thickness for the histochemical study of NADPH diaphorase activity. The sections were incubated at 371C for 10 40 min in 50 mM Tris-HCl buffer (pH 8.0) con taining 1 mM NADPH, 0.2 mM NBT and 0.2% Triton X-100, and the reaction was terminated by washing them with 50 mM Tris-HC1 buffer (pH 8.0). The specimens were examined and photographed by a light miroscope.
The cerebral metabolism-improving drugs were kindly donated. Idebenone was from Takeda Chemical Indus tries, Ltd. (Osaka); calcium hopantenate was from Tanabe Seiyaku Co., Ltd. (Osaka); propentofylline was from Hoechst Japan, Ltd. (Tokyo); and brovincamine was from Sandoz Pharmaceuticals (Tokyo). Other chemi cals were of commercially available reagent grades. To elucidate the effects of cerebral metabolism-improv ing drugs on the production of nitric oxide in the brain, the direct actions of these drugs on NADPH diaphorase in the mouse brain were examined using the post mitochondrial fraction of brain homogenate. As shown in Fig. 1 , NADPH diaphorase was markedly activated by the addition of idebenone (10-5 M) . In contrast, other drugs, such as propentofylline, hopantenate and brovin camine, failed to cause any notable increase in the activity of this enzyme at the same concentration. Because the drug concentrations used here are considered to be sufficient to produce their actions, based on the blood con centrations at which their therapeutic effects are exhibit ed, it therefore seems reasonable to conclude that NADPH diaphorase is activated only by idebenone under the experimental conditions used here. Furthermore, the stimulatory action of idebenone on the diaphorase activ ity was also shown to be dependent on its concentration, and a slight increase in the enzyme activity was already ob served at 3 x 10-6 M idebenone (Fig. 2) . The results ob tained in these in vitro studies clearly indicate that idebe none can directly activate NADPH diaphorase, thus sug gesting the possibility that this drug may stimulate the production of nitric oxide presumably through its stimula tory action on nitric oxide synthase in the brain.
Histochemical studies of NADPH diaphorase were furthermore carried out to test whether the activity of NADPH diaphorase in a particular region of the mouse brain was specifically altered by idebenone. As shown in Fig. 3 , the choroid plexus revealed a highly positive reac tion to NADPH diaphorase, and the positive enzyme staining was observed in the epithelial cells and the nerve fibers in the blood vessel (Fig. 3, A and B) . On the other hand, the enzyme was positive in the neurons of both the paraventricular nucleus and supraoptic nucleus (pictures not shown). In addition, the staining of NADPH diaph orase in these specific cells and neurons was markedly intensified by the addition of idebenone to the reaction mixture (Fig. 3, C and D as compared with A and B) . These results indicate that NADPH diaphorase is activat ed by idebenone, and this activation is similarly observed in different types of cells in different regions of the mouse brain.
The findings presented here suggest that idebenone may improve the cerebral metabolism and blood flow as a con sequence of stimulation of nitric oxide production, thus providing evidence for a possible involvement of nitric oxide in the mechanism underlying the improving action of this drug on neurological disorders. In fact, the previ ous study has shown that L-arginine, a substrate for nitric oxide production, can reduce the infarct size in a focal ischemia and this effect is likely due to the dilation of cerebral blood vessels (11) . However, conclusive evidence quired to obtain a definite answer to this critical question.
